Table 1.
Baseline Characteristics by Occurrence of MACE
| Variable | MACE (n=67) | No MACE (n=452) | P Value |
|---|---|---|---|
| Age, y | 54 (45, 62) | 51 (42, 58) | 0.04 |
| Sex (female), n (%) | 38 (56.7) | 314 (68.1) | 0.07 |
| Hypertension, n (%) | 29 (43.3) | 181 (40.2) | 0.64 |
| Creatinine (mg/dL), median (Q1, Q3) | 1 (0.8, 1.2) | 1 (0.9, 1.1) | 0.73 |
| Type 2 diabetes mellitus, n (%) | 6 (9.0) | 37 (8.2) | 0.83 |
| Body mass index, kg/m2 | 28.8 (24.6, 32.9) | 27.8 (24.0, 31.9) | 0.46 |
| Statin use, n (%) | 28 (41.8) | 166 (36.7) | 0.43 |
| Estrogen use, n (%) | 15 (22.4) | 95 (21.0) | 0.80 |
| Total cholesterol, mg/dL | 190 (153, 247) | 189 (166, 220) | 0.32 |
| LDL, mg/dL | 119 (77, 146) | 107 (85, 134) | 0.15 |
| HDL, mg/dL | 50 (38, 61) | 52 (43, 63) | 0.23 |
| Triglycerides/HDL ratio, mg/dL | 2.5 (1.7, 3.6) | 2.2 (1.4, 4.1) | 0.52 |
| Triglycerides, mg/dL | 122 (90, 175) | 117 (81, 177) | 0.62 |
HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein; MACE, major adverse cardiovascular events.